Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Secure Translational Funding

The Translational Research Office (TRO) manage a number of devolved funding streams targeting early stage proof-of-concept projects and have extensive knowledge of the UK translational funding landscape. We can help source the most appropriate funding scheme for projects and ensure that the most compelling cases for support are generated. Securing funding enables projects to progress along the translational path, de-risking future investment.

Illustration of financial concepts, including graphs, calculator and percentages

Key Activities

The TRO administrate translational proof-of-concept funding through the Medical and Life Sciences Translation Fund (MLSTF). The fund is open to all University of Oxford researchers and provides consolidated internal proof of concept funding for translational medical and life sciences projects.The next call will open in 2021

The TRO also identify the most appropriate external grant funding source for a project. A few of the translational research funding schemes available to researchers are:

The TRO supports developing robust project plans and compelling applications for funding. Our Translational Research Managers can support grant writing activities, provide project management support and advise on long-term translational research strategies.

The TRO works closely with Oxford University Innovation (OUI), the Medical Sciences Business Partnerships Office and University of Oxford's Research Services to ensure appropriate expertise and advice is sought at key stages in project development.

In this section